Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Evaluation of RBS2418 in Combination With Tremelimumab Plus Durvalumab in Participants With Advanced Unresectable Hepatocellular Carcinoma
Apply
RBS2418 & STRIDE
Evaluation of RBS2418 in Combination With Tremelimumab Plus Durvalumab in Participants With Advanced Unresectable Hepatocellular Carcinoma
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step